Upadacitinib for the treatment of psoriatic arthritis

Diogo Fonseca, Miguel Nogueira, Tiago Torres

Article Type

Review

Published

This article offers a review of the more recently published results on the Janus kinase inhibitor inhibitor upadacitinib and its use in the treatment of psoriatic arthritis.

Read more

Considerations for the US health-system pharmacist in a world of biosimilars

Andrea Zlatkus CRHC, Todd Bixby RPh, Kavitha Goyal MD

Article Type

Editorial

Published

This editorial article provides an overview of the evolving healthcare landscape shaped by the entry of multiple biosimilars, including for a given reference product, and their impact on the healthsystem pharmacist with respect to formulary assessment, implementation, and education of various health-system stakeholders, including patients.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.